Published in J Bacteriol on August 01, 2002
The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever. PLoS Genet (2007) 1.43
The dif/Xer recombination systems in proteobacteria. PLoS One (2009) 1.28
YAPI, a new Yersinia pseudotuberculosis pathogenicity island. Infect Immun (2004) 1.20
Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08
Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis. J Pathog (2011) 1.05
Sudden onset of pseudotuberculosis in humans, France, 2004-05. Emerg Infect Dis (2008) 0.92
Population structure and evolution of pathogenicity of Yersinia pseudotuberculosis. Appl Environ Microbiol (2010) 0.85
Xer recombinase and genome integrity in Helicobacter pylori, a pathogen without topoisomerase IV. PLoS One (2012) 0.83
Linkage of the horizontally acquired ypm and pil genes in Yersinia pseudotuberculosis. Infect Immun (2005) 0.79
Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells. Infect Immun (2015) 0.76
Yersinia pseudotuberculosis septicemia and HIV. Emerg Infect Dis (2005) 0.75
A High-Coverage Yersinia pestis Genome from a Sixth-Century Justinianic Plague Victim. Mol Biol Evol (2016) 0.75
First case of postaneurysmal prosthetic vascular infection due to a nonsuperantigenic Yersinia pseudotuberculosis strain. J Clin Microbiol (2010) 0.75
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol (1988) 31.85
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun (1991) 15.39
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (1999) 10.34
Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol (2000) 9.51
Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A (2001) 9.40
Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol Microbiol (1991) 6.44
The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol (1998) 5.21
A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol (1993) 5.02
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
How Salmonella became a pathogen. Trends Microbiol (1997) 2.69
Staphylococcal enterotoxin A is encoded by phage. Science (1985) 2.57
dif, a recA-independent recombination site in the terminus region of the chromosome of Escherichia coli. New Biol (1991) 2.49
Transposition of the Escherichia coli insertion element gamma generates a five-base-pair repeat. Proc Natl Acad Sci U S A (1979) 2.47
Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene. J Bacteriol (1988) 2.41
Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D. J Bacteriol (1989) 2.41
An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis (1984) 2.14
Staphylococcal enterotoxin A gene is associated with a variable genetic element. Proc Natl Acad Sci U S A (1984) 1.79
Analysis and possible role of hyperrecombination in the termination region of the Escherichia coli chromosome. J Bacteriol (1991) 1.71
Site-specific recombination promoted by a short DNA segment of plasmid R1 and by a homologous segment in the terminus region of the Escherichia coli chromosome. New Biol (1991) 1.65
Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol (2001) 1.62
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J Bacteriol (1986) 1.49
Identification of a transposon Tn3 sequence required for transposition immunity. Proc Natl Acad Sci U S A (1983) 1.47
Bacteriophage association of streptococcal pyrogenic exotoxin type C. J Bacteriol (1989) 1.40
Identification of PhoP-PhoQ activated genes within a duplicated region of the Salmonella typhimurium chromosome. Microb Pathog (1998) 1.35
Silencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene. Infect Immun (2001) 1.29
Clinical manifestations of Yersinia pseudotuberculosis infection in children. Eur J Clin Microbiol Infect Dis (1989) 1.22
Complete DNA sequence of Yersinia enterocolitica serotype 0:8 low-calcium-response plasmid reveals a new virulence plasmid-associated replicon. Infect Immun (2001) 1.14
Staphylococcal enterotoxin B gene is associated with a discrete genetic element. J Bacteriol (1988) 1.13
Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol (1993) 1.08
Mercury resistance transposons of gram-negative environmental bacteria and their classification. Res Microbiol (2001) 1.08
Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer. Mol Microbiol (2000) 1.06
Penicillinase plasmid-linked genetic determinants for enterotoxins B and C1 production in Staphylococcus aureus. Infect Immun (1985) 1.04
Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol (1993) 1.02
Superantigen bacterial toxins: state of the art. Toxicon (2001) 1.01
Yersinia enterocolitica produces superantigenic activity. J Immunol (1992) 1.00
Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice. Infect Immun (2000) 0.99
Molecular typing of Yersinia pseudotuberculosis by using an IS200-like element. J Clin Microbiol (1996) 0.97
Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains. J Clin Microbiol (1995) 0.94
Two outbreaks of Yersinia pseudotuberculosis 5a infection in Japan. Scand J Infect Dis (1989) 0.93
Nucleotide sequences involved in the neolysogenic insertion of filamentous phage Cf16-v1 into the Xanthomonas campestris pv. citri chromosome. Virology (1988) 0.90
DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J Immunol (1995) 0.89
A 140 base-pair DNA segment from the kanamycin resistance region of plasmid R1 acts as an origin of replication and promotes site-specific recombination. J Mol Biol (1984) 0.86
Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen. FEBS Lett (1997) 0.85
Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice. Microbiol Immunol (1997) 0.82
High genomic polymorphism in Yersinia pseudotuberculosis. Contrib Microbiol Immunol (1995) 0.80
Characterization of human T-cell responses to Yersinia enterocolitica superantigen. Hum Immunol (1995) 0.80
Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J Infect Dis (2005) 2.09
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol Microbiol (2003) 1.53
Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity. Infect Immun (2002) 1.49
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa. J Immunol (2010) 1.43
Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis. PLoS Pathog (2010) 1.36
The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect Immun (2004) 1.34
Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun (2006) 1.23
High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg (2006) 1.22
YAPI, a new Yersinia pseudotuberculosis pathogenicity island. Infect Immun (2004) 1.20
Transcriptome analysis of Yersinia pestis in human plasma: an approach for discovering bacterial genes involved in septicaemic plague. Microbiology (2007) 1.19
Autophagosomes can support Yersinia pseudotuberculosis replication in macrophages. Cell Microbiol (2010) 1.16
Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology (2007) 1.05
Body lice, yersinia pestis orientalis, and black death. Emerg Infect Dis (2010) 1.04
A case of bupropion-induced stuttering. Gen Hosp Psychiatry (2012) 0.99
Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun (2004) 0.96
Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: new insights into two-component system regulon plasticity in bacteria. Int J Med Microbiol (2007) 0.95
NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol (2006) 0.95
The Yersinia pseudotuberculosis Yut protein, a new type of urea transporter homologous to eukaryotic channels and functionally interchangeable in vitro with the Helicobacter pylori UreI protein. Mol Microbiol (2002) 0.93
Sudden onset of pseudotuberculosis in humans, France, 2004-05. Emerg Infect Dis (2008) 0.92
Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression. BMC Microbiol (2008) 0.91
Genes encoding specific nickel transport systems flank the chromosomal urease locus of pathogenic yersiniae. J Bacteriol (2002) 0.89
Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine (2009) 0.89
Analysis of Yersinia pestis gene expression in the flea vector. Adv Exp Med Biol (2007) 0.86
Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse. Infect Immun (2004) 0.86
Two-component system regulon plasticity in bacteria: a concept emerging from phenotypic analysis of Yersinia pseudotuberculosis response regulator mutants. Adv Exp Med Biol (2007) 0.85
[SIMS REIN: a multi-source information system for end-stage renal disease]. C R Biol (2002) 0.85
Similarities of Kawasaki disease and Yersinia pseudotuberculosis infection epidemiology. Pediatr Infect Dis J (2007) 0.85
Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response. J Infect Dis (2013) 0.83
Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase. Bioorg Med Chem (2008) 0.83
Hypoxic single-pass isolated hepatic perfusion of hypotonic Cisplatin: safety study in the pig. Ann Surg Oncol (2009) 0.82
CHROMagar Yersinia, a new chromogenic agar for screening of potentially pathogenic Yersinia enterocolitica isolates in stools. J Clin Microbiol (2013) 0.81
A dynamic Web application within an n-tier architecture: a Multi-Source Information System for end-stage renal disease. Stud Health Technol Inform (2003) 0.81
Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. PLoS One (2012) 0.80
In silico comparison of Yersinia pestis and Yersinia pseudotuberculosis transcriptomes reveals a higher expression level of crucial virulence determinants in the plague bacillus. Int J Med Microbiol (2010) 0.79
An iron-regulated LysR-type element mediates antimicrobial peptide resistance and virulence in Yersinia pseudotuberculosis. Microbiology (2009) 0.79
Linkage of the horizontally acquired ypm and pil genes in Yersinia pseudotuberculosis. Infect Immun (2005) 0.79
Characterizing consumer health terminology in the breast cancer field. Stud Health Technol Inform (2010) 0.77
Function and regulation of the Salmonella-like pmrF antimicrobial peptide resistance operon in Yersinia pseudotuberculosis. Adv Exp Med Biol (2003) 0.75
Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity. Adv Exp Med Biol (2003) 0.75
Therapeutic potential of Yersinia anti-inflammatory components. Adv Exp Med Biol (2007) 0.75
Proposed reclassification of Pasteurella lymphangitidis Sneath & Stevens 1990 as Yersinia pseudotuberculosis. Int J Syst Evol Microbiol (2013) 0.75
A Multi-Source Information System via the Internet for End-Stage Renal Disease: Scalability and Data Quality. Stud Health Technol Inform (2005) 0.75
Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system. Adv Exp Med Biol (2003) 0.75